A high level of CXCL1 in the blood is associated with a low risk of ESCC [58], which may reflect either antitumor mechanisms involving CXCL1 in the early stages of ESCC development or a protective effect. This evidence concerns the gene CXCL1 and esophageal squamous cell carcinoma.